Li Yuliang<br/>Chairman (Founder)

• Responsible for the strategic development of the Company<br> • More than 20 years of industrial operation management and investment experience, in-depth layout of the pharmaceutical industry, with entrepreneurial pioneering, innovative spirit and strong resource integration abilities<br> • Successively establishing Chifeng Sailintai Pharmaceutical Co., Ltd. and Beijing Puqi Pharmaceutical Technology Co., Ltd.<br> • Successfully launching and managing Chifeng Meinian Great Health Management Company Limited, Chifeng Ciming Health Management Company Limited, Chifeng Qinghe Hospital<br> • Winner of Excellent Individual of Independent Entrepreneurship in Inner Mongolia Autonomous Region

Dr. Yunlong Du <br>CEO and CMO (Partner, Director)

• Responsible for strategy development, overall operation and clinical management of the Company<br> • Having led the R&D, NDA preparation and submission of several projects of Hua Medicine, and successfully assisting the company to be listed in Hong Kong in 2018<br> • More than 20 years of experience in early stage R&D, clinical development and the overall process of product launch in famous multinational pharmaceutical companies such as Pfizer and GSK.<br> • Having managed several Phases 1-4 clinical trials, medical affairs, and drug safety management in the therapeutic areas of dermatology, metabolism and neurology, and participated in the preparation and submission of several NDAs<br> • MD, Albany Medical College, US, Bachelor of Medicine, Peking University, US; Certified Professional Medical Practitioner in the United States.<br> • Having been included in Shanghai's "Thousand Talents Plan", with 15 invention patents and more than 20 publications.

Li Hua <br>CFO (Chief Financial Officer)

• Responsible for corporate financial management, financial strategy and capital management.<br> • Rich experience in financing and capital operation, has led a number of well-known companies in the preparation of domestic A-share and New Third Board listing, and is experienced in the planning, construction and operation of group financial system.<br> • Nearly 20 years working experience in famous multinational companies and private listed companies such as Fosun Pharma, Zhengji Pharma, Wanfeng Aowei.

Dr. Lisheng Kang <br>Chief Technology Officer（CTO）

• Responsible for the work of the CMC Centre and the Formulation Research Centre, directing the establishment of the topical formulation R&D platform.<br> • Over 20 years of experience in new product development and CMC team management in foreign multinational pharmaceutical companies, and experience in leading the R&D/manufacturing system of CMC in domestic pharmaceutical companies. Experience in the development of various dosage forms including semi-solid, solid and injectable, including specialty formulations such as complex creams, nanoemulsions, nano suspensions, oral controlled release formulations, etc. Served as the director of the API solid form strategy committee of a multinational pharmaceutical company.<br> • Worked in the US R&D centres of multinational pharmaceutical companies such as Celgene, GSK, Pfizer, Eli Lilly, etc., responsible for the formulation and CMC cross-disciplinary development of new products in Phase I-III clinical stage and commercialization, and has directly participated or led the pharmacological development of several successful products.<br> • Ph.D. in Pharmacy, University of Georgia, USA; B.S. in Pharmacy, Peking University

Ye Dong<br>Vice President Production & Quality

• Responsible for company quality assurance and commercial production management<br> • Extensive work experience in drug development, production management,quality management, technology management, industrialization and technology transfer, and pharmaceutical plant engineering planning and construction<br> • Over 20 years working experience in pharmaceutical industry, worked in ZBD Pharmaceutical, Fujian Cosunter Pharmaceutical, Aosaikang Pharmaceutical, etc<br> • Nanjing Tech University - Master of Pharmaceutical Engineering

Atopic Dermatitis

Atopic dermatitis is also known as atopic dermatitis, atopic eczema, Besnier's somatic itchy rash or genetic allergic eczema.